Brief: Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer

Shuttle Pharmaceuticals Holdings

10/04/2025 21:52

April 10 (Reuters) - Shuttle Pharmaceuticals Holdings Inc SHPH.O:

SHUTTLE PHARMACEUTICALS- FILES PROVISIONAL PATENT APPLICATION FOR PSMA LIGAND CONJUGATES TO TREAT PROSTATE CANCER

Source text: ID:nGNX24fc7c

Further company coverage: SHPH.O

 ((Reuters.Briefs@thomsonreuters.com;))